Back
OpGen 10K Form
Sell
33
OPGN
OpGen
Last Price:
0.45
Seasonality Move:
-2.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-14 | 10Q | OPGN/OpGen Quarterly |
2023-08-14 | 10Q | OPGN/OpGen Quarterly |
2023-05-15 | 10Q | OPGN/OpGen Quarterly |
2022-11-14 | 10Q | OPGN/OpGen Quarterly |
2022-08-12 | 10Q | OPGN/OpGen Quarterly |
2022-05-13 | 10Q | OPGN/OpGen Quarterly |
Receive OPGN News And Ratings
See the #1 stock for the next 7 days that we like better than OPGN
OPGN Financial Statistics
Sales & Book Value
Annual Sales: | $2.61M |
---|---|
Cash Flow: | $-3.03M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.27 |
Price / Book: | 1.64 |
Profitability
EPS (TTM): | -6.51000 |
---|---|
Net Income (TTM): | $-26.16M |
Gross Margin: | $-816.7K |
Return on Equity: | -325.17% |
Return on Assets: | -103.94% |
OpGen Earnings Forecast
Key OpGen Financial Ratios
- The Gross Profit Margin over the past 10 years for OPGN is -31.32%.
- The Selling, General & Administrative Expenses for OPGN have been equal to 507.38% of Gross Profit Margin.
- The Research & Development expenses have been 313.48% of Revenue.
- The Interest Expense is -8.73% of Operating Income.
- The Net Earning history of OPGN is -1,429.96% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 8 years.
OpGen Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | OPGN |
CUSIP: | 68373L |
Website: | opgen.com |
Debt
Debt-to-Equity Ratio: | 3.44 |
---|---|
Current Ratio: | 0.28 |
Quick Ratio: | 0.06 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |